Company / Book Value per Share
LENZ Therapeutics, Inc. Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$10.333
FY2025
5-year range
-$47.324 / $13.28
FY2021-FY2025
Trend
+7.7%
vs FY2024
Sector context
#54 of 209
Health Care
What the data says
At $10.333, LENZ Therapeutics, Inc.'s book value per share ranks #54 of 209 in the Health Care sector. Improved from -$47.324 to $10.333 over the past 2 years.
Based on SEC 10-K filings.
$10.333 in FY2025.
Improved from -$47.324 to $10.333 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#54 of 209 in Health CareTop 26% of 209This company $10.333 Sector average $189.406
▼
-94.5% below sector average
Key checks
Key Insights
- In FY2025, book value per share increased 7.7% year-over-year.
- Ranks #54 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2021.
- Lowest book value per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.333 | +7.7% |
| FY2024 | $9.59 | +120.3% |
| FY2023 | -$47.324 | -10644.5% |
| FY2022 | -$0.44 | -103.3% |
| FY2021 | $13.28 | +146.4% |
| FY2020 | -$28.636 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026